Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Cancer history and melanoma risk

Principal Investigator
Name
Sonja Berndt
Degrees
PhD, PharmD
Institution
NCI, DCEG, OEEB
Position Title
Investigator
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-10
Initial CDAS Request Approval
Dec 13, 2012
Title
Cancer history and melanoma risk
Summary
Melanoma shares several genetic susceptibility loci with other cancers, suggesting that at least some etiologic factors may be shared between melanoma and other cancers. Recently, we evaluated the association between confirmed cancers and the subsequent diagnosis of melanoma in 42,420 from the Health Professionals’ Follow-up Study over a 24-year period (1986–2010). We identified 540 melanoma cases during the follow-up. Interestingly, history of prostate cancer was associated with a significantly increased risk of subsequent melanoma with multivariate-adjusted relative risk (RR) of 1.81 (95% confidence interval (CI), 1.30-2.50). We would like to follow-up this finding in the PLCO Cancer Screening Trial to see if history of cancer, particularly prostate cancer, is also associated with the risk of melanoma.
Aims

The specific aim of this study is to evaluate the association between history of cancer, particularly prostate cancer, and the risk of melanoma in the PLCO Trial.

Collaborators

Jiali Han (Harvard University)